One-center, Observational, Non-interventional, Prospective Study of the Efficacy of Azilsartan Medoxomil in Patients With Arterial Hypertension Associated With Stable Ischemic Heart Disease and Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 31 May 2019
Price : $35 *
At a glance
- Drugs Azilsartan medoxomil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms AcADEME
- 28 May 2019 Status changed from not yet recruiting to recruiting.
- 01 Jun 2018 New trial record